Shao Yiye, Ni Yanbo, Yang Jing, Lin Xutao, Li Jun, Zhang Lixia
Department of Neurology, Jinshan Hospital, Fudan University, Shanghai, China (mainland).
School of Basic Medical Sciences, Binzhou Medical University, Yantai, Shandong, China (mainland).
Med Sci Monit. 2016 Jun 23;22:2152-60. doi: 10.12659/msm.899419.
BACKGROUND It is widely recognized that astaxanthin (ASX), a member of the carotenoid family, has strong biological activities including antioxidant, anti-inflammation, and immune-modulation activities. Previous studies have confirmed that ASX can effectively inhibit hepatoma cells in vitro. MATERIAL AND METHODS MTT was used to assay proliferation of mice H22 cells, and flow cytometry was used to determine apoptosis and cell cycle arrest of H22 cells in vitro and in vivo. Moreover, anti-tumor activity of ASX was observed in mice. RESULTS ASX inhibited the proliferation of H22 cells, promoted cell necrosis, and induced cell cycle arrest in G2 phase in vitro and in vivo. CONCLUSIONS This study indicated that ASX can inhibit proliferation and induce apoptosis and cell cycle arrest in mice H22 hepatoma cells in vitro and in vivo.
背景 虾青素(ASX)作为类胡萝卜素家族的一员,具有抗氧化、抗炎和免疫调节等强大的生物活性,这已得到广泛认可。先前的研究证实,ASX在体外可有效抑制肝癌细胞。
材料与方法 采用MTT法检测小鼠H22细胞的增殖情况,运用流式细胞术测定H22细胞在体内外的凋亡及细胞周期阻滞情况。此外,观察了ASX在小鼠体内的抗肿瘤活性。
结果 ASX在体内外均能抑制H22细胞的增殖,促进细胞坏死,并诱导细胞周期阻滞于G2期。
结论 本研究表明,ASX在体内外均可抑制小鼠H22肝癌细胞的增殖,并诱导其凋亡和细胞周期阻滞。